Title: Sulfenylation of Human Liver and Kidney Microsomal Cytochromes P450 and Other Drug-Metabolizing Enzymes as a Response to Redox Alteration.

Authors: Albertolle, Matthew E; Phan, Thanh T N; Pozzi, Ambra; Guengerich, F Peter

Published In Mol Cell Proteomics, (2018 05)

Abstract: The lumen of the endoplasmic reticulum (ER) provides an oxidizing environment to aid in the formation of disulfide bonds, which is tightly regulated by both antioxidant proteins and small molecules. On the cytoplasmic side of the ER, cytochrome P450 (P450) proteins have been identified as a superfamily of enzymes that are important in the formation of endogenous chemicals as well as in the detoxication of xenobiotics. Our previous report described oxidative inhibition of P450 Family 4 enzymes via oxidation of the heme-thiolate cysteine to a sulfenic acid (-SOH) (Albertolle, M. E. et al. (2017) J. Biol. Chem. 292, 11230-11242). Further proteomic analyses of murine kidney and liver microsomes led to the finding that a number of other drug-metabolizing enzymes located in the ER are also redox-regulated in this manner. We expanded our analysis of sulfenylated enzymes to human liver and kidney microsomes. Evaluation of the sulfenylation, catalytic activity, and spectral properties of P450s 1A2, 2C8, 2D6, and 3A4 led to the identification of two classes of redox sensitivity in P450 enzymes: heme-thiolate-sensitive and thiol-insensitive. These findings provide evidence for a mammalian P450 regulatory mechanism, which may also be relevant to other drug-metabolizing enzymes. (Data are available via ProteomeXchange with identifier PXD007913.).

PubMed ID: 29374135

MeSH Terms: Animals; Biocatalysis; Cysteine/metabolism; Cytochrome P-450 Enzyme System/metabolism*; Humans; Hydrogen Peroxide/toxicity; Kidney/enzymology*; Mice, Transgenic; Microsomes, Liver/enzymology*; Oxidation-Reduction; Pharmaceutical Preparations/metabolism*; Recombinant Proteins/metabolism; Staining and Labeling; Sulfenic Acids/metabolism*; Sulfhydryl Compounds/metabolism